Skip to main content
. 2019 Apr 1;30(7):1162–1169. doi: 10.1093/annonc/mdz117

Table 2.

Characteristics of lung cancers and study outcome by study arm, throughout the 10-year follow-up

  Total Control arm Intervention arm P-values
(N = 4099) (N = 1723) (N = 2376)
Lung cancer incidence 158 (3.9%) 60 (3.5%) 98 (4.1%) 0.29
Lung cancer rate (per 100 000) 407.0 372.6 431.5 0.37
Person-years (incidence) 38 816 16 102 22 714  
Lung cancer stage    
I 62 (39.2%) 13 (21.7%) 49 (50.0%) 0.0004a
II 9 (5.7%) 5 (8.3%) 4 (4.1%)  
III 26 (16.5%) 10 (16.7%) 16 (16.3%)
IV 61 (38.6%) 32 (53.3%) 29 (29.6%)
Lung resection    
None 78 (49.4%) 44 (73.3%) 34 (34.7%) <0.0001b
Pneumonectomy 1 (0.6%) 0 1 (1.0%)  
Lobectomy/segmentectomy 79 (50.0%) 16 (26.7%) 63 (64.3%)
Lung cancer histology    
Squamous cell carcinoma 30 (24.4%) 12 (30.0%) 18 (21.7%) 0.25c
Adenocarcinoma 78 (63.4%) 23 (57.5%) 55 (66.3%)
Small cell carcinoma 10 (8.1%) 4 (10.0%) 6 (7.2%)
Large cell carcinoma 5 (4.1%) 1 (2.5%) 4 (4.8%)
Carcinoma NOSd 35 20 15
Lung cancers not screen detected 86 (54.4%) 59 (98.3%) 27 (27.6%) <0.0001
Total deaths 243 (5.9%) 106 (6.2%) 137 (5.8%) 0.61
Overall mortality rate (per 100 000) 618.4 653.9 593.5 0.45
Lung cancer deaths 80 (2.0%) 40 (2.3%) 40 (1.7%) 0.14
Lung cancer mortality rate (per 100 000) 203.6 246.8 173.3 0.12
Person-years (mortality) 39 293 16 210 23 083  

Resection for benign histology was not accounted in the table, it is thereafter summarized: 3 cases in LDCT arm, rate of resection for benign histology 4.5% (3/67); 1 case in control arm, rate of resection for benign histology 5.9% (1/17).

a

Proportion of stage I.

b

Proportion of lung resection compared with no lung resection.

c

Carcinoma NOS excluded.

d

Carcinoma NOS: carcinoma not otherwise specified.